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Migraine is a common neurological disorder characterized by episodic headaches
with specific features, presenting familial aggregation. Migraine is associated with
episodic vertigo, named Vestibular Migraine (VM) whose diagnosis mainly rely on clinical
history showing a temporary association of symptoms. Some patient refers symptoms
occurring in pediatric age, defined “episodic symptoms which may be associated with
migraine.” The aim of this cross sectional observational study was to assess migraine-
related clinical features in VM subjects. For the purpose, 279 patients were recruited
in different centers in Europe; data were collected by a senior neurologist or ENT
specialist through a structured questionnaire. The age of onset of migraine was 21.8
± 9. The duration of headaches was lower than 24 h in 79.1% of cases. Symptoms
accompanying migrainous headaches were, in order of frequency, nausea (79.9%),
phonophobia (54.5%), photophobia (53.8%), vomiting (29%), lightheadedness (21.1%).
Visual or other auras were reported by 25.4% of subjects. A familial aggregation was
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referred by 67.4%, while migraine precursors were reported by 52.3% of subjects.
Patients reporting nausea and vomiting during headaches more frequently experienced
the same symptoms during vertigo. Comparing our results in VM subjects with previously
published papers in migraine sufferers, our patients presented a lower duration of
headaches and a higher rate of familial aggregation; moreover some common characters
were observed in headache and vertigo attacks for accompanying symptoms like nausea
and vomiting and clustering of attacks.
Keywords: Vestibular Migraine, vertigo, headache, migraine, clinical diagnosis, vestibular disorders
INTRODUCTION
Migraine is one of the most prevalent neurological disorder with
an estimated number ofmore than 80millions sufferers inUS and
Europe (1, 2). According to the International Headache Society
(HIS) criteria, typically the migrainous headaches last between 4
and 72 h and present at least two of the following features:
• Unilateral.
• Pulsating.
• Moderate or severe intensity of pain.
• Aggravated by, or resulting in the avoidance of, routine
physical activity.
In addition, there is at least one of:
• Nausea and vomiting during migraine attacks.
• Photophobia and phonophobia.
Visual and other aura may precede the headache (3, 4).
In clinical practice the association of vertigo and migraine is
of common observation. Particularly, the complaint of vertigo
is more elevated in migraineurs than in general population,
ranging from 30 to 50% (5, 6). In previous years, various
terms such as migraine-associated dizziness, migraine-related
vertigo, and migrainous vertigo have been used to describe
episodic vestibular symptoms in patients with migraine when
an alternative diagnosis has been ruled out (7, 8). Since clinical
examination is usually normal during the vertigo-free period
(9) the diagnosis mainly relies on clinical history. Recently, a
joint committee between the International Headache Society and
the Bárány Society established the following diagnostic criteria
for both definite and probable vestibular migraine (VM), the
nosological disorder in which migraine is associated with the
occurrence of vestibular symptoms and other causal factors are
ruled out (10).
Definite VM:
A. At least five episodes with vestibular symptoms of a moderate
or severe intensity, lasting 5min to 72 h.
B. Current or previous history of migraine with or without aura
according to the International Classification of Headache
Disorders (ICHD).
C. One or more migraine features with at least 50% of the
vestibular episodes:
• Headache with at least two of the following characteristics:
one-sided location, pulsating quality, moderate or
severe pain intensity, aggravation by routine physical
activity
• Photophobia and phonophobia
• Visual aura
D. Not better accounted for by another vestibular or ICHD
diagnosis
In order to diagnose probable VM, only one of the criteria B or C
must be observed.
The diagnostic criteria for definite VM are included in the 3rd
edition of the International Classification of Headache Disorders
(ICHD-III), published in 2013, where it appears in the appendix
for new disorders (3).
Familial aggregation has been widely observed in migraine
(11) and episodic vertigo (12), and both disorders may arise from
the interplay between genetic predisposition and environmental
factors.
Finally, ICHD-III included four migraine equivalents in
infancy and childhood, defined as “episodic syndromes which
may be associated with migraine”: cyclic vomiting, abdominal
pain, benign paroxysmal vertigo, and benign paroxysmal
torticollis. For some of them, an involvement of the vestibular
system can be proposed. Motion sickness in pediatric subjects,
consisting of autonomic signs and symptoms occurring during
movement, has also been studied as a possible migraine precursor
(13).
The aim of our work was to assess the features of
headaches, accompanying symptoms, familial history and
migraine precursors in a large sample of subjects with a
diagnosis of definite VM and the relationship with accompanying
symptoms of vertigo episodes.
MATERIALS AND METHODS
Patients
In this cross-sectional observational multicentric study, 279
subjects were recruited in different centers in Italy and Spain
between January 2016 and March 2017. Participating centers
(in order of number of enrolled patients) were Naples (51
patients), Milan (45), Brescia (45), Florence (23), Turin (20),
Granada (19), Pisa (16), Parma (15), Salamanca (12), Matera (12),
Siena (10), Madrid (6), and Chieti (5). All patients presented
a diagnosis of definite VM according to the Bárány/ICHD
Society criteria (10). To be included, all patients should have
at least five attacks of headache with migrainous features.
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Of the 279 subjects, 235 (84.2%) were female. The age at
inclusion was 45.8 ± 13.8 years (range 18–78 years). All
patients were interviewed by a senior neuro-otologist. A six
months’ follow-up was required to confirm the diagnoses before
inclusion.
Six patients were excluded after the follow up since they
developed a low-frequencies sensorineural hearing loss possible
related to hydrops. The centers were tertiary referral outpatient
clinics or vertigo clinics in general hospitals. This study was
approved by the local ethics committees in all of the participating
centers. Data were saved on eCRF in our hospital, only
senior specialists were given username/password and they were
asked to include patients evaluated in their clinical activity
presenting criteria for definite VM and signing informed
consent.
Methods
A full neurotological examination including video HIT,
video-nystagmography with caloric testing, an audiometric
examination and a CNSMRI with contrast was performed before
inclusion. Patients with low frequency sensorineural hearing
loss were not included. A diagnosis of migraine was confirmed
by a senior neurologist. A structured questionnaire was
designed to record the headache characters and accompanying
symptoms.
The questionnaire also included patient’s age at onset of
vestibular symptoms and headache, and a set of questions
to determine the accompanying symptoms occurring during
the attacks of headache (nausea, vomiting, phono\photophobia,
blurred or double vision, feeling lightheaded, weakness of arms
and legs, visual aura). Nausea and vomiting occurring during
vestibular episodes were also saved. Accompanying symptoms
were considered only when occurring in at least 50% of
attacks.
Patients were also asked if any of their family members, i.e.,
another relative in the first or second degree, suffered from
migraine in the family.
Finally, the following migraine precursors were investigated
in the questionnaire: motion sickness, cyclic vomiting, episodic
abdominal pain, episodic vertigo, torticollis (13). To diagnose
migraine precursors, criteria of ICHD III beta version were
observed (3).
A positive history for cyclic vomiting has been considered
when the patient referred episodes (at least 5) of severe
vomiting without apparent cause, lasting for at least 1 h or days
alternating with symptom-free periods and occurring with the
same stereotyped symptoms and intensity in childhood. Episodic
abdominal pain was considered when patients reported recurrent
attacks of moderate to severe midline abdominal pain, associated
with vasomotor symptoms, nausea and vomiting, lasting 2–72 h
and with normality between episodes. Torticollis was diagnosed
when the patient reported recurrent and stereotyped episodes
of head tilt to one side, perhaps with slight rotation, which
remit spontaneously occurring in infants and small children,
with onset in the first year. BPV was diagnosed in subjects
reporting recurrent brief attacks of vertigo, occurring without
warning and resolving spontaneously, in otherwise healthy
children.
We included motion sickness among them, although not
commonly accepted, and probably better definable migraine
marker.
Statistical Analysis
Absolute and relative frequencies of each symptom were
calculated and compared between different groups using Chi-
squared statistics. Quantitative variables are presented as mean
± standard deviation and unpaired Student’s t-tests were
used to compare them. A p < 0.05 was considered to be
statistically significant. A Spearman test was performed to
investigate the association between different variables and a
Bonferroni correction was applied. One full regression model
was calculated to assess the independent role of migraine
precursors on age of onset of vertigo. We used SPSS software
version 17.0 (SPSS, Inc., Chicago, IL, USA) for statistical
analysis.
RESULTS
In our sample the first headache occurred at 21.8 ± 9 (ranging
between 12 and 50 years old), while the first vertigo at 37.4 ±
13.1 (ranging between 17 and 70). In 19 cases patients reported
synchronous occurrence of headache and vertigo; these patients
presented a lower age of onset of both disorders (mean age of 19.8
± 2.1, p < 0.05). The female\male ratio was 5.3/1.
The number of attacks of headache in the last 12 months was
1.09 (ranging between 0.5 and 2).
In Table 1 are reported the localization of the headaches in
our sample, while Table 2 reports the duration of headaches in
the sample; no difference was detected for the age of onset of
headaches in subgroups with different duration of headaches.
Investigators were asked to save the most frequent location and
duration of headaches.
Accompanying symptoms occurring during headaches are
reported in Table 3.
A correlation has been found between nausea and vomiting
during headaches and during vertigo; in the subgroup of
223 patients referring nausea in at least 50% of headaches,
TABLE 1 | Localization of headaches; in the second column the total number of
subjects (and percentages).
Localization of headaches Total number (and percentages)
Above right or left eyebrow 26 (9.3%)
Above both eyebrows 24 (8.6%)
Behind right or left eye 26 (9.3%)
Behind both eyes 24 (8.6%)
Right or left temporal region 48 (17.2%)
Both temporal regions 68 (24.4%)
Back of the head on right or left 27 (9.7%)
Back of the head on both sides 36 (12.9%)
Most frequent locations have been saved.
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145 (65%) also referred nausea during vertigo, while 27
(48%) of 56 subjects without nausea during headaches
(χ2 = 5.35, p = 0.02). Similarly, in the subgroup of 81
patients referring vomiting during headaches, 46 (56.8%)
also referred vomiting during vertigo, while 8 (4%) in the
subgroup of 198 subjects with a negative history of vomiting
during headaches reported vomiting during vertigo (χ2 = 107,
p ≤ 0.0001).
Seventy-one (25.4%) subjects referred visual or other auras
preceding headaches; they did not present differences compared
with the total sample for the age of onset of headache (21.2± 8.3).
One hundred-eighty eight (67.4%) subjects reported familial
cases of headaches with migrainous features among relatives of
first or second degree. Among 71 subjects with aura, 62 (87.3%)
reported familial cases of migraine (p= 0.001).
One hundred forty-six subjects (52.3%) reported a positive
history for at least one of migraine precursors. The total number
and frequency are reported in the Table 4.
A Spearman test demonstrated a correlation between a
positive history for at least one precursor and age of occurrence
of the first headache (t = 2.31, p = 0.02). No statistics has been
found between the presence of precursors and clinical features of
headaches.
Finally, 40 patients (14.3%) reported headaches clustered in
specific periods, while 54 for vertigo attacks (19.3%). A strong
correlation has been found between the two variables (t = 9.75,
p ≤ 0.0001).
TABLE 2 | Duration of headache attacks; in the second column the total number
of subjects (and percentages).
Duration of headache Total number (and percentage)
Within 2 h 17 (6.2%)
3–4 h 43 (15.5%)
5–12 h 55 (19.8%)
12–24 h 104 (37.6%)
1–3 days 58 (20.8%)
More than 1 week 2 (0.1%)
The most frequent duration was saved; patients were included if they had at least 5
headaches lasting more than 4 h.
TABLE 3 | Accompanying symptoms of headaches; in the second column the
total number of subjects (and percentages) referring symptom in at least 50% of
attacks.
Accompanying symptoms Total number (and percentage)
Phonophobia 152 (54.5%)
Photophobia 150 (53.8%)
Lightheadedness 59 (21.1%)
Blurred\Double vision 22 (7.9%)
Loss of vision 17 (6.1%)
Weakness of arms and legs 23 (9.5%)
Nausea 223 (79.9%)
Vomiting 81 (29%)
DISCUSSION
Vestibular Migraine (VM) is a common variant of migraine,
resulting in recurrent vestibular symptoms in association with
migraine features. It is the most frequent central cause of
episodic vertigo and the second most important cause of vertigo
overall (14).VM diagnosis is primarily based on clinical history
(15). Admittedly, symptoms may be heterogeneous among VM
patients; in a previous paper we presented data regarding
vestibular manifestations on a sample of subjects fulfilling VM
criteria (16).
From this background, VM-Phenotypes project has the
purpose to better elucidate the patients’ characteristics and
phenotypes by assessing a large sample of probands with definite
VM diagnosis.
Data were collected during clinical activity in specialized
Headache and ENT Departments.
The VM diagnosis rely on very accurate anamnestic self-
report data, focused on migraine and vestibular symptoms: since
the structured interview was performed by a Senior Neurologist
or a Senior Otologist in tertiary University Clinics, we were able
to consecutively include 279 patients with a confirmed diagnosis
of definite VM.
In our Caucasian group of VM patients, 84.2% were females
with an age at inclusion of 45.8 years. This VM female prevalence
is higher in comparison with Caucasian female:male migraine
(with or without aura) prevalence at the same age (3.5:1) (17).
The onset of migraine preceded the onset of vertigo by around
15 years, while the age of the first episode of migraine in VM
patients does not demonstrate differences with that of general
migraineurs population (2).
Interestingly, in VM patients reporting a synchronous onset
of migraine and vertigo, the age of onset of both is lower. On the
opposite, we found no difference for onset of headaches in VM
patients with or without aura.
Considering the well-known aggregation of migraine within
families, it could be speculated a genetic contribution in this
group of VM patients.
Moreover, focusing on putative genetic aspects, we found a
considerable high rate of VM patients with a familial history
of migraine (67.4%) compared to previously published data
on general population of migraineurs reporting an heritability
ranging from 34 to 57% (18).
As far as migraine symptoms are concerned, in our VM
patients’ sample duration of migraine is variable, although a high
rate of VM patients (79.1%) reported attacks lasting <24 h. This
TABLE 4 | Migraine precursors in VM patients; in the second column the total
number (and percentage) of patients.
Migraine precursors
Motion sickness 117 (41.9%)
Cyclic vomiting 24 (8.6%)
Episodic abdominal pain 18 (6.5%)
Episodic vertigo (BPV) 12 (4.3%)
Torticollis 12 (4.3%)
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is in contrast with classical studies whereas among women,∼71%
of attacks last longer than 24 h (19).
In our group of VM patients we found a high percentage
(69%) of subjects referring at least one of the pediatric precursors
of migraine, with a particular preminence of motion sickness
(42.8%).
As far as the rate of migraine precursors in pediatric age is
concerned, these data are in line with previous published works
(20).
In our knowledge this is the first work describing
a possible relationship between migraine precursors
and onset of headache on adulthood. Considering data
on migraine precursor, we can speculate about some
possible predisposing factor in childhood to eventually
develop VM.
As a final consideration, in VM subjects some “specific
features” are maintained in vertigo and headache attacks;
above all, patients reporting nausea and vomiting
during headaches more easily experience nausea and
vomiting during vertigo. Moreover, clustering of
headaches and vertigo more easily happens in specific
patients. It could be speculated that an “autonomic
hypersensitivity” in these subjects may play a role in the
finding.
In summary, in our group of Caucasian VM patients,
preminent phenotypic migraine features are: female
patients with migraine attacks of moderate to severe
intensity, duration less of 24 h, low frequency (one attack
per month) and predisposing factors such as familiarity
and precursors in pediatric age (motion sickness in
particular).
Finally, we want to underline some possible limitations of our
study. Above all, evaluation of familial cases and clinical history
of migraine precursors may present some uncertainty, since these
data were collected mainly during the structured interview with
the patient.
Admittedly, diagnosis of VM remains a challenge for
Neurologists and ENT specialists.
The knowledge of disease course and phenotype
characteristics from the pediatric age to adulthood could
be essential to provide an early diagnosis, a reliable prognosis
and a valuable care for VM patients.
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